Biosysen Limited

As of December 31, 2025, Biosysen Limited carries a market capitalization of 122.73M, placing it among publicly traded companies globally. Its enterprise value stands at 214.83M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of December 31, 2025, Biosysen Limited has 1.19B shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, Biosysen Limited maintains a current ratio of 0.23, meaning it holds 0.2x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2025.

As of the close on October 23, 2026, Biosysen Limited's stock has gained approximately 104.44% over the past 52 weeks. The 50-day moving average sits at 0.18, while the 200-day moving average is 0.13.

As of December 31, 2025, Biosysen Limited holds 2.44M in cash and equivalents against 162.19M in total debt, resulting in a net debt position of 41.13M. Total book value stands at -35.25M, with working capital of -66.68M providing operational flexibility.

Biosysen Limited's most recent stock split took place on July 24, 2026 with a 358:435 split ratio.